High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer

Xiaodong Xie, TAO HAN, Yaling Han, Wanqing Xie, Ranran Zhang, Li Zhu, Zhaozhe Liu, Fang Guo, Hengyu Li, Yuan Sheng
  • OncoTargets and Therapy, July 2015, Dove Medical Press
  • DOI: 10.2147/ott.s81214

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication


The following have contributed to this page: Dr Tao Han and Guo Fang Guo